Atlas Trials

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

Clinical trial NCT01038856 · TERMINATED

Trial details

NCT number
NCT01038856
Sponsor
University of Oklahoma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Polycythemia Vera
Start date
2009-12-01
Primary completion
2012-12-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.